Center of Experimental and Applied Cutaneous Physiology
|Michael J O Rourke|
Scotia Vision Consultants
Currently there are only 4 sustained release ocular drug delivery systems ever approved worldwide treating blinding eye diseases. This presentation will cover these systems, discuss new technologies under current development, the challenges to overcome and how they can ultimately be successfully commercialized.